Instant Healthcare Diagnostics

Toku Eyes developed a multi-modal artificial intelligence platform for instant healthcare diagnostics, personalised prognostics and general health risk assessments using retinal images to screen for preventable blindness.

Confronting Preventable Blindness

Preventable blindness is growing rapidly due to aging populations and diabetes

  • Diabetic Retinopathy (140 million people)
  • Age-related Macular Degeneration [AMD] (195 million people)
  • Cataracts (100 million people)
  • Glaucoma (60 million people)

Toku Eyes developed a better way, confronting preventable blindness with an AI platform named THEIA

THEIA can currently screen for 80% of the sources of preventable vision loss using artificial intelligence and digital feedback.

Our
Vision

Accessible and affordable eyecare for all, with no disease missed

  • Providing the earliest possible diagnosis of the disease and its root causes
  • Offering the most accurate and granular disease grading, and comprehensive eye health check
  • Utilising individualised, patient-specific prognostics
  • Developing accurate screening, diagnosis and severity grading. Immediately, every time
  • Enabling rapid expansion of diagnosis access and earlier treatment for patients
  • Expanding the capabilities and accessibility of current eye imaging technologies into diabetes and cardiovascular diseases

Meet
THEIA

We are a world class inter-disciplinary team

We are a world class interdisciplinary team

Our team includes Endocrinologists, Ophthalmologists, Optometrists, AI Specialists, global business and regulatory experts linked to University of Auckland and private and public health care providers.

Dr Ehsan Vaghefi
CEO – NZ

Dr David Squirrell
CMO – NZ

Mr Gerard Wallace
Executive Director – AU

Mr John Frantzis
CCO – US

Ask us about your health screening requirements

    Dr. Ehsan Vaghefi, CEO